Frazier Healthcare Partners Buys MatrixCare from ResMed

Frazier Healthcare Partners, a private equity firm focused exclusively on the healthcare sector, has reached an agreement to acquire MatrixCare from ResMed, the sleep and respiratory health technology company. The deal marks a significant portfolio shift for ResMed, which has been reassessing its software assets as it refocuses on its core hardware and connected device business.

MatrixCare is a well-established software platform serving the post-acute and long-term care market, providing electronic health records and care management tools to skilled nursing facilities, senior living communities, and home health agencies. Its customer base sits at the intersection of an aging U.S. population and an accelerating push toward value-based care — making it an attractive standalone asset for a specialized healthcare investor.

Read more A 70-Year-Old Beekeeper Fights to Save His Family's Honey Legacy →

For Frazier Healthcare Partners, the acquisition fits a consistent investment thesis: backing companies that address structural inefficiencies in healthcare delivery. Long-term care software remains fragmented and under-digitized relative to the acute-care hospital segment, suggesting meaningful runway for a focused operator to drive both organic growth and strategic add-ons.

From ResMed's perspective, divesting MatrixCare allows the company to concentrate capital and management attention on its device ecosystem and remote patient monitoring capabilities — areas where it holds stronger competitive differentiation. The sale reflects a broader trend among large medtech companies of shedding non-core software subsidiaries acquired during the digital health boom of the late 2010s.

The financial terms of the transaction were not disclosed. Continue reading at SeekingAlpha.